» Articles » PMID: 38979040

Influence of Non-pharmaceutical Interventions During the COVID-19 Pandemic on Respiratory Viral Infections - a Prospective Population-based Cohort Study

Overview
Specialty Public Health
Date 2024 Jul 9
PMID 38979040
Authors
Affiliations
Soon will be listed here.
Abstract

Trial Registration: DRKS.de, German Clinical Trials Register (DRKS), Identifier: DRKS00023418, Registered on 28 October 2020.

Citing Articles

Re-emergence of Mycoplasma pneumoniae before and after COVID-19 pandemic in Germany.

Waldeck F, Kramer T, Boutin S, Matten J, Kramer J, Rupp J BMC Infect Dis. 2025; 25(1):318.

PMID: 40050786 PMC: 11884198. DOI: 10.1186/s12879-025-10657-4.

References
1.
Liu Y, Huang L, Wang J . Reduction of acute respiratory illness (ARI) due to a voluntary workplace influenza vaccination program: who are more likely to get the benefit?. J Occup Health. 2004; 46(6):455-60. DOI: 10.1539/joh.46.455. View

2.
Chow E, Uyeki T, Chu H . The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol. 2022; 21(3):195-210. PMC: 9574826. DOI: 10.1038/s41579-022-00807-9. View

3.
Yan H, Zhai B, Yang F, Wang P, Zhou Y . The Impact of Non-pharmacological Interventions Measures Against COVID-19 on Respiratory Virus in Preschool Children in Henan, China. J Epidemiol Glob Health. 2023; 14(1):54-62. PMC: 11043251. DOI: 10.1007/s44197-023-00168-3. View

4.
Wong A, Barrero Guevara L, Goult E, Briga M, Kramer S, Kovacevic A . The interactions of SARS-CoV-2 with cocirculating pathogens: Epidemiological implications and current knowledge gaps. PLoS Pathog. 2023; 19(3):e1011167. PMC: 9994710. DOI: 10.1371/journal.ppat.1011167. View

5.
Spiliopoulos L . On the effectiveness of COVID-19 restrictions and lockdowns: Pan metron ariston. BMC Public Health. 2022; 22(1):1842. PMC: 9526209. DOI: 10.1186/s12889-022-14177-7. View